Cargando…
Denosumab improves clinical manifestations of hypophosphatemic osteomalacia by adefovir-induced Fanconi syndrome: a case report
BACKGROUND: Adefovir dipivoxil is a nucleotide analogue that is approved for treatment of chronic hepatitis B. Adefovir dipivoxil is associated with proximal tubular dysfunction, resulting in Fanconi syndrome, which can cause secondary hypophosphatemic osteomalacia. We describe a case of a patient w...
Autores principales: | Kunii, Tomohisa, Iijima, Toshie, Jojima, Teruo, Shimizu, Masanori, Kase, Masato, Sakurai, Shintaro, Kogai, Takahiko, Usui, Isao, Aso, Yoshimasa |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6475105/ https://www.ncbi.nlm.nih.gov/pubmed/31003599 http://dx.doi.org/10.1186/s13256-019-2018-7 |
Ejemplares similares
-
The SGLT2 Inhibitor Canagliflozin Prevents Carcinogenesis in a Mouse Model of Diabetes and Non-Alcoholic Steatohepatitis-Related Hepatocarcinogenesis: Association with SGLT2 Expression in Hepatocellular Carcinoma
por: Jojima, Teruo, et al.
Publicado: (2019) -
Osteomalacia and Fanconi Syndrome Induced by Adefovir
por: Matsuoka, Natsumi, et al.
Publicado: (2019) -
No Negative Impact of a National State of Emergency by COVID-19 Outbreak on Hemoglobin A1c Levels in Patients With Type 2 Diabetes Living in Semi-Rural Japan
por: Aso, Yoshimasa, et al.
Publicado: (2021) -
Hypophosphatemic Osteomalacia Associated with Adefovir-induced Fanconi Syndrome Initially Diagnosed as Diabetic Kidney Disease and Vitamin D Deficiency
por: Koda, Ryo, et al.
Publicado: (2018) -
Synergistic effects of liver fibrosis and sarcopenia on endothelial dysfunction and arterial stiffness in patients with type 2 diabetes
por: Jojima, Teruo, et al.
Publicado: (2022)